Healio (5/24, Marabito) reports, “Rural counties in the United States had lower odds of reaching maximum potential buprenorphine treatment capacity,” researchers concluded after using “county-level Drug Enforcement Administration…data to determine the presence, absence and availability of buprenorphine treatment or opioid treatment programs” in US counties. The study also revealed that “counties with high populations of people with disabilities or without insurance also had lower odds of maximum treatment capacity with buprenorphine, a medication for opioid use disorder.” The findings were published online ahead of print in the July issue of the journal Drug and Alcohol Dependence.
Related Links:
— “Medication for opioid use disorder less accessible in rural counties “Maria Marabito, Healio, May 24, 2022